Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
103 studies found for:    Emphysema: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Emphysema: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Conditions: Emphysema;   COPD
Intervention: Device: IBV® Valve System
2 Unknown  EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Bronchoscopic Lung Volume Reduction (BLVR)
3 Completed Endobronchial Valve for Emphysema Palliation Trial (VENT)
Conditions: Chronic Obstructive Pulmonary Disease;   Emphysema
Intervention: Procedure: Emphasys Endobronchial Valve and procedure
4 Terminated Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Device: Emphasys Endobronchial Valve (EBV) Device and Procedure
5 Active, not recruiting LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)
Condition: Emphysema
Intervention: Device: LVRC System
6 Completed
Has Results
Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)
Condition: Alpha 1-Antitrypsin Deficiency
Interventions: Drug: Alpha1-Proteinase Inhibitor (Human);   Drug: Albumin (Human) 20%, United States Pharmacopeia (USP)
7 Unknown  EASE Trial: Exhale Airway Stents for Emphysema
Condition: Emphysema
Interventions: Device: Exhale® Drug-Eluting Stent;   Device: Sham control
8 Active, not recruiting Endobronchial Valve in Patients With Heterogeneous Emphysema
Conditions: Chronic Obstructive Pulmonary Disease;   Emphysema
Intervention: Device: Zephyr endobronchial valve placement
9 Active, not recruiting To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr EBV
Conditions: COPD;   Heterogeneous Emphysema
Intervention: Device: ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve
10 Completed National Emphysema Treatment Trial (NETT)
Conditions: Emphysema;   Lung Diseases;   Lung Diseases, Obstructive;   Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Lung volume reduction surgery
11 Unknown  The Value of Bronchoscopic Lung Volume Reduction by Endobronchial Valves in Patients With Single Lung Transplantation and Overinflation of the Native Lung
Condition: Native Lung Overinflation in Patients That Underwent Single Lung Transplantation Due to Emphysema
Intervention: Device: lung volume reduction using the Zephyr device
12 Completed Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)
Condition: Emphysema
Interventions: Device: Lung Volume Reduction Coil (LVRC) (PneumRx);   Device: Control
13 Terminated Thorax Enlarging Surgery: a Novel Surgical Approach to Emphysema
Conditions: COPD;   Emphysema
Intervention: Procedure: Chest wall enlargement
14 Unknown  AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
15 Unknown  Endoscopic Lung Volume Reduction After Catheter-based CV Measurement in Patients With Heterogeneous Emphysema and Complete Interlobar Fissures
Condition: Heterogeneous Emphysema
Intervention: Device: Implantation of valves (IBV)
16 Completed TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
Condition: Emphysema
Interventions: Drug: Placebo;   Drug: RAR Gamma
17 Recruiting Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Interventions: Drug: Inhaled Treprostinil;   Drug: Placebo
18 Completed Bronchoscopic Lung Volume Reduction Using Blood
Condition: Emphysema
Interventions: Other: Autologous blood;   Other: Normal saline
19 Unknown  ART - Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial
Condition: Respiratory Distress Syndrome, Adult
Interventions: Other: ART Strategy;   Other: ARDSNet Strategy
20 Recruiting Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
Condition: Pulmonary Emphysema
Interventions: Biological: Mesenchymal stem cells;   Other: Reference therapy: 400 mL of 0.9% NaCl solution

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.